Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston blog main
boston top stories
2
×
clinical trials
deals
eli lilly
fda
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
abeona therapeutics
achaogen
affordable care act
alnylam pharmaceuticals
alzheimer's
amgen
astrazeneca
avapritinib
biosimilar
biotech
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
celiac disease
chris collins
coherus biosciences
cstone pharmaceuticals
cydan development
detroit blog main
detroit top stories
egfr
european medicines agency
fisogatinib
flatiron health
foamix pharmaceuticals
gene therapy
genentech
What
wins
2
×
alzheimer’s
approval
bio
blueprint
cancer
candidate
congress
currently
democrats
divided
drug
elections
fallout
fda
losses
marketing
medicines
midterm
muscle
pact
panel
plenty
political
postpartum
regulatory
ret
review
roche
roundup
search
stake
team
terms
took
week’s
Language
unset
Current search:
wins
×
photo
×
" boston top stories "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel